IL-1, a prototypic pro-inflammatory cytokine that presents itself in two forms, i.e., IL-1α and IL-Iβ, seems to be involved in different molecular mechanisms underlying primary breast cancer development and the formation of metastasis in bone. This evidence concerns the gene IL1A and breast carcinoma.